HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER
Clinical trials for HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial aims to control advanced breast cancer growth
Disease control Recruiting nowThis study is testing two different doses of a drug called dalpicicl, combined with the hormone therapy letrozole, for people with a specific type of advanced breast cancer. It aims to see which dose is better at controlling the cancer and delaying its progression. The trial will…
Matched conditions: HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: wanghaibo • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First human trial launches for experimental cancer 'Breaker' drug
Disease control Recruiting nowThis is the first human study testing a new experimental drug called BBO-10203 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find safe doses and see how the body processes the drug, both alone and when combined with oth…
Matched conditions: HR POSITIVE HER2 NEGATIVE ADVANCED BREAST CANCER
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC